For example, it is shown in Figure 2F that, in the GSE164571 dataset, compared with healthy control, CD69, LRRC32 and SNAI1 were downregulated in COVID-19 patients with or without cancer, while 19 other genes were upregulated in COVID-19 patients with or without cancer. This evidence concerns the gene CD69 and cancer.